"Pharmaceutical-Grade Heparin Sodium Powder: Sourcedfrom GMP-Compliant Facilities"

2025-07-21 11:15

"Pharmaceutical-Grade Heparin Sodium Powder: Sourcedfrom GMP-Compliant Facilities"  

Meta Description:  

Seeking pharmaceutical-grade Heparin Sodium powder? Blue EyesBiotech supplies USP/EP-compliant, GMP-certified Heparin Sodium API from auditedfacilities. Request batch records & regulatory support today: [email protected]| www.blueeyes-bio.com  


Article Content:  


For pharmaceutical manufacturers requiring highest-purityHeparin Sodium, Blue Eyes Biotech delivers fully certified API powdermanufactured in WHO-GMP & EU-GMP compliant facilities. Our documentation-richapproach ensures seamless regulatory compliance for global buyers.  


WhyPharmaceutical Companies Trust Our Heparin Sodium  


1. Uncompromising Purity Standards  

- ≥180 IU/mg potency (consistently exceeds USP/EP monographs)  

- Endotoxin levels <0.05 EU/mg (testedvia LAL kinetic chromogenic)  

- Protein content ≤0.1% (verified by SEC-HPLC)  


2. Complete Regulatory Documentation  

- EDMF/CEP files available forreference  

- Full DMF support (Type II & III)  

- Batch-specific release packagesincluding:  

  -NMR conformity reports  

  -Residual solvent analysis  

  -Heavy metal certificates  


3. Specialized Pharmaceutical Applications  

- Injectable anticoagulants (pre-filledsyringes, IV solutions)  

- Medical device coatings (stents,catheters)  

- Advanced drug formulations (LMWHderivatives)  


OurGMP Manufacturing Edge  

✔Dedicated Heparin purification suites(ISO Class 8 cleanrooms)  

✔Phase-appropriate validation fromR&D to commercial scale  

✔21 CFR Part 11 compliant electronicbatch records  


QualityVerification Process  

1. Raw Material Control  

   -DNA-traceable porcine intestinal mucosa  

   -Vendor-qualified sourcing network  


2. In-Process Testing  

   -Real-time potency monitoring  

   -Process analytical technology (PAT) integration


3. Final Release Criteria  

   -Full compendial testing (USP<209>, EP 2.8.1)  

   -Stability studies (ICH Q1A conditions)  


For technical dossiers or audit requests:  

[email protected]  

www.blueeyes-bio.com


Name:
Message:
Verification code:
Submit
Comment